The effect of agomelatine on 5HT2C receptors in humans: A clinically relevant mechanism?

Psychopharmacology

Volumn 221, Issue 1, 2012, Pages 177-178

  Norman, Trevor R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; CYPROHEPTADINE; DOPAMINE; HISTAMINE H1 RECEPTOR; MIRTAZAPINE; NORADRENALIN; OLANZAPINE; RITANSERIN; SEROTONIN 2C RECEPTOR;

ANTIDEPRESSANT ACTIVITY; BINDING AFFINITY; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SLOW WAVE SLEEP;

ACETAMIDES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; RECEPTOR, SEROTONIN, 5-HT2C;

EID: 84859627372     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2656-6     Document Type: Letter

References (13)

1. Bertaina-Anglade V, Drieu C, Boyer PA, Mocaer E (2006) Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model. Behav Pharmacol 17:703-713
2. Chagraoui A, Protais P, Filloux T, Mocaer E (2003) Agomelatine (S20098) antagonises the penile erections induced by the stimulation of 5HT2C receptors in Wistar rats. Psychopharmacology 170:17-22 (Pubitemid 37372474)
3. De Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P et al (2010) Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 9:628-642
4. Leproult R, Van Onderbergen A, L'Hermite-Baleriaux M, Van Cauter E, Copinschi G (2005) Phase-shifts of the 24-hr rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol 63:298-304 (Pubitemid 41233447)
5. 2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharm Exp Ther 306:954-964
6. Molteni R, Calabrese F, Pisoni S, Gabriel C, Mocaer E, Racagni G, Riva MA (2010) Synergistic mechanisms in the modulation of the neurotrophic BDNF in the rat prefrontal cortex following acute agomelatine administration World J Biol Psychiatry 11:148-153
7. 2C antagonist, S32006. Eur J Pharmacol 674:27-32
8. Quera Salva M-A, Vanier B, Laredo J, Hartley S, Chapotot F, Moulin C, Lofaso F, Guilleminault C (2007) Major depressive disorder, sleep EEG and agomelatine: an open label study. Int J Neuropsychopharmacol 10:691-696 (Pubitemid 47517524)
9. C receptors in humans? Psychopharmacology 213:653-655
10. Papp M, Gruca P, Boyer P-A, Mocaer E (2003) Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 28:694-703
11. Saitou K, Kankeo Y, Sugimoto Y, Chen Z, Kamei C (1999) Slow wave inducing effects of first generation H1-antagonists. Biol Pharm Bull 22:1079-1082 (Pubitemid 29507947)
12. Thakkar M (2011) Histamine in the regulation of wakefulness. Sleep Med Rev 15:65-74
13. Tokunaga S, Takeda Y, Shinomiya K, Hirase M, Kamei C (2007) Effects of some H1-antagonists on the sleep-wake cycle in sleep-disturbed rats. J Pharmacol Sci 103:201-206 (Pubitemid 46294652)